Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Jan-24 7:06 PM View:  | Meisner Derek M Chief Legal Officer & Corp Sec | Acumen Pharmaceuticals, Inc. (ABOS) | 19-Jan-24 | Sale (Planned) | 8,933 | $3.48 | $31,048.40 | (8%) 117.8K to 108.87K | |
| 19-Jan-24 7:07 PM View: | Oconnell Daniel Joseph President and CEO Director | Acumen Pharmaceuticals, Inc. (ABOS) | 19-Jan-24 | Sale (Planned) | 15,200 | $3.47 | $52,753.10 | (3%) 517.68K to 502.49K | |
| 19-Jan-24 7:04 PM View: | Barton Russell Chief Operating Officer | Acumen Pharmaceuticals, Inc. (ABOS) | 18-Jan-24 | Sale (Planned) | 2,833 | $3.73 | $10,555.20 | (3%) 99.7K to 96.87K | |
| 19-Jan-24 7:05 PM View: | Siemers Eric Chief Medical Officer | Acumen Pharmaceuticals, Inc. (ABOS) | 18-Jan-24 | Sale (Planned) | 3,124 | $3.71 | $11,603.80 | (3%) 120.7K to 117.58K | |
| 19-Jan-24 7:05 PM View: | Zuga Matt CFO & Chief Business Officer | Acumen Pharmaceuticals, Inc. (ABOS) | 18-Jan-24 | Sale (Planned) | 4,242 | $3.70 | $15,716.60 | (2%) 215.69K to 211.44K | |
| 04-Jan-24 4:23 PM View: | Barton Russell Chief Operating Officer | Acumen Pharmaceuticals, Inc. (ABOS) | 02-Jan-24 | Grant | 73,000 | -- | -- | 273% 26.7K to 99.7K | |
| 04-Jan-24 4:22 PM View: | Meisner Derek M Chief Legal Officer & Corp Sec | Acumen Pharmaceuticals, Inc. (ABOS) | 02-Jan-24 | Grant | 91,000 | -- | -- | 340% 26.8K to 117.8K | |
| 04-Jan-24 4:21 PM View: | Siemers Eric Chief Medical Officer | Acumen Pharmaceuticals, Inc. (ABOS) | 02-Jan-24 | Grant | 94,000 | -- | -- | 352% 26.7K to 120.7K | |
| 04-Jan-24 4:18 PM View: | Oconnell Daniel Joseph President and CEO Director | Acumen Pharmaceuticals, Inc. (ABOS) | 02-Jan-24 | Grant | 401,000 | -- | -- | 344% 116.69K to 517.68K | |
| 04-Jan-24 4:20 PM View: | Zuga Matt CFO & Chief Business Officer | Acumen Pharmaceuticals, Inc. (ABOS) | 02-Jan-24 | Grant | 106,000 | -- | -- | 97% 109.69K to 215.69K | |
| 18-Aug-23 6:31 PM View: | Ives Jeffrey L. Director | Acumen Pharmaceuticals, Inc. (ABOS) | 17-Aug-23 | Planned Option Sale | 41,949 | $6.49 | $272,334.00 | (100%) 41.95K to 0 | |
| 18-Aug-23 6:31 PM View: | Ives Jeffrey L. Director | Acumen Pharmaceuticals, Inc. (ABOS) | 17-Aug-23 | Option Exercise | 41,949 | $0.75 | $31,519.30 | 100% 0 to 41.95K | |
| 25-Jul-23 4:30 PM View: | Ra Capital Management, LLC Director 10% Owner | Acumen Pharmaceuticals, Inc. (ABOS) | 21-Jul-23 | Purchase | 5,161,290 | $7.75 | $40,000,000.00 | 53% 9.77M to 14.93M | |
| 18-Jan-23 4:21 PM View: | Meisner Derek M Chief Legal Office & Corp Sec | Acumen Pharmaceuticals, Inc. (ABOS) | 17-Jan-23 | Grant | 26,800 | -- | -- | 100% 0 to 26.8K | |
| 18-Jan-23 4:27 PM View: | Zuga Matt CFO and Chief Business Officer | Acumen Pharmaceuticals, Inc. (ABOS) | 17-Jan-23 | Grant | 33,500 | -- | -- | 44% 76.19K to 109.69K | |
| 18-Jan-23 4:19 PM View: | Barton Russell Chief Operating Officer | Acumen Pharmaceuticals, Inc. (ABOS) | 17-Jan-23 | Grant | 26,700 | -- | -- | 100% 0 to 26.7K | |
| 18-Jan-23 4:23 PM View: | Siemers Eric Chief Medical Officer | Acumen Pharmaceuticals, Inc. (ABOS) | 17-Jan-23 | Grant | 26,700 | -- | -- | 100% 0 to 26.7K | |
| 18-Jan-23 4:22 PM View: | Oconnell Daniel Joseph President and CEO Director | Acumen Pharmaceuticals, Inc. (ABOS) | 17-Jan-23 | Grant | 114,000 | -- | -- | 4246% 2.69K to 116.69K | |
| 03-Jan-23 5:23 PM View: | Zuga Matt CFO and Chief Business Officer | Acumen Pharmaceuticals, Inc. (ABOS) | 29-Dec-22 | Option Exercise | 50,000 | $1.19 | $59,500.00 | 191% 26.19K to 76.19K | |
| 02-Dec-21 4:41 PM View: | Oconnell Daniel Joseph President and CEO Director | Acumen Pharmaceuticals, Inc. (ABOS) | 30-Nov-21 | Option Exercise | 1,118 | $4.47 | $4,997.46 | 71% 1.57K to 2.69K | |
| 08-Jul-21 6:18 PM View: | Zuga Matt Chief Financial Officer | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Conversion | 26,187 | -- | -- | 100% 0 to 26.19K | |
| 08-Jul-21 4:32 PM View: | Ra Capital Management, LLC Director 10% Owner | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Purchase | 1,875,000 | $16.00 | $30,000,000.00 | 24% 7.9M to 9.77M | |
| 08-Jul-21 6:17 PM View: | Stalfort Sean Director | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Conversion | 131,595 | -- | -- | 96% 137.32K to 268.92K | |
| 08-Jul-21 6:35 PM View: | Manning Paul B 10% Owner | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Conversion Duplicate | 3,608,470 | -- | -- | 4022% 89.71K to 3.7M | |
| 08-Jul-21 6:15 PM View: | Hardie Robert D. 10% Owner | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Conversion | 3,608,470 | -- | -- | 4022% 89.71K to 3.7M | |
| 08-Jul-21 6:14 PM View: | Hardie Robert D. 10% Owner | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Purchase | 750,000 | $16.00 | $12,000,000.00 | 10% 7.53M to 8.28M | |
| 08-Jul-21 6:17 PM View: | Stalfort Sean Director | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Purchase | 35,000 | $16.00 | $560,000.00 | 13% 268.92K to 303.92K | |
| 08-Jul-21 6:35 PM View: | Manning Paul B 10% Owner | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Purchase Duplicate | 312,500 | $16.00 | $5,000,000.00 | 8% 3.7M to 4.01M | |
| 08-Jul-21 5:21 PM View: | Sands Capital Ventures Disc... 10% Owner | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Conversion | 2,967,080 | -- | -- | 264% 1.12M to 4.09M | |
| 08-Jul-21 6:14 PM View: | Hardie Robert D. 10% Owner | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Conversion | 3,201,160 | -- | -- | 74% 4.33M to 7.53M | |
| 08-Jul-21 6:16 PM View: | Oconnell Daniel Joseph President and CEO Director | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Conversion | 123 | -- | -- | 9% 1.42K to 1.54K | |
| 08-Jul-21 6:16 PM View: | Oconnell Daniel Joseph President and CEO Director | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Exercise (in-the money or at-the-money) | 35 | $4.47 | $156.45 | 2% 1.54K to 1.58K | |
| 08-Jul-21 4:32 PM View: | Ra Capital Management, LLC Director 10% Owner | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Conversion | 7,895,770 | -- | -- | 100% 0 to 7.9M | |
| 08-Jul-21 6:17 PM View: | Stalfort Sean Director | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Conversion | 130,180 | -- | -- | 1822% 7.14K to 137.32K | |
| 08-Jul-21 6:13 PM View: | Fountain Nathan B Director | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Purchase | 6,250 | $16.00 | $100,000.00 | 100% 0 to 6.25K | |
| 08-Jul-21 5:21 PM View: | Sands Capital Ventures Disc... 10% Owner | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Purchase | 450,000 | $14.88 | $6,696,000.00 | 11% 4.09M to 4.54M | |
| 08-Jul-21 6:15 PM View: | Hardie Robert D. 10% Owner | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Purchase | 312,500 | $16.00 | $5,000,000.00 | 8% 3.7M to 4.01M | |
| 08-Jul-21 6:16 PM View: | Oconnell Daniel Joseph President and CEO Director | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Payment of Exercise | 10 | $16.00 | $160.00 | (< 1%) 1.58K to 1.57K |
